Diffuse malignant melanomas of the uvea. A clinico-pathologic study of 39 patients;Diffuse maligne melanome der uvea. Eine klinisch-histopathologische studie uber 39 patienten

Klinische Monatsblatter fur Augenheilkunde

Volumn 213, Issue 6, 1998, Pages 331-340

  Braun, Ulrike C ^a   Rummelt, Volker C ^a   Naumann, Gottfried O H ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Anterior uvea; Diffusely growing malignant uveal melanomas; Extrascleral spread; Iris melanoma; Iris and ciliary body melanoma; Iris ciliary body choroidal melanoma; Malignant melanocyte; Malignant melanoma; Vascular network; Vessel parameter

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EYE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MELANOMA; PROGNOSIS; SCHOOL CHILD; SURVIVAL TIME; TUMOR BIOPSY; UVEA TUMOR;

EID: 0032425147     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1034998     Document Type: Article

References (67)

1. Aretsen JJ, Green WR. Melanoma of the iris: report of 72 cases treated surgically. Ophthalmic Surg 1975; 6:23-37
2. Ashton N. Primary tumors of the iris. Br J Ophthalmol 1964; 48:650-668
3. Augsburger JJ, Eagle RC, Jr., Chiu M, Shields JA. The effect of preenucleation radiotherapy on mitotic activity of chorioidal and ciliary body melanomas. Ophthalmology 1987; 94:1627-1630
4. Barr CC, McLean, Zimmerman LE. Uveal melanoma in children and adolescents. Arch Ophthalmol 1981; 99:2133-2136
5. Blodi FC, Apple DJ. Uveal melanocytic tumors. Int Ophthalmol Clin 1980; 87:33-42
6. Brown D, Boniuk M, Font RL. Diffuse malignant melanomas of iris with metastases. Surv Ophthalmol 1990; 34:357-364
7. Char DH, Phillips TL. The potential for adjuvant radiotherapy in choroidal melanoma. Arch Ophthalmol 1982; 100:247-248
8. Char DH, Phillips TL, Andejeski Y, Crawford JB, Kroll S. Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol 1988; 106:21-26
9. Carlson DW, Alward WLM, Folberg R. Agressive Nevus of the iris with secondary glaucoma in a child. Am J Ophthalmol 1995; 119:367-368
10. Charteris DG. Progression of an iris melanoma over 41 years. Br J Ophthalmol 1990; 74:566-567
11. Collaborative Ocular Melanoma Study Group. Accuracy of diagnosis of choroidal melanoma in the Collaborative Ocular Melanoma Study. Arch Ophthalmol 1990; 108:1268-1273
12. Cox DR. Regression models and life tables. J Royal Stat Soc Series B 1972; 34:187-220
13. Davidorf FH. The melanoma controversy, a comparison of choroidal, cutaneous, and iris melanomas. Surv Ophthalmol 1981; 25:373-377
14. De la Cruz PO, Jr., Specht CS, McLean IW. Lymphocytic infiltration in uveal malignant melanoma. Cancer 1990; 65:112-115
15. Diener-West M, Hawkins BS, Markowitz JA, Schacut AP. A review of mortality from choroidal melanoma. II a meta-analysis of 5-year mortality rates following enucleation, 1966 trough 1988. Arch Ophthalmol 1992; 110:245-250
16. Draeger J, Naumann G. Das Verhalten des intraokulren Drucks beim Melanoblastom der Uvea. Ophthalmologica 1966; 151:670-682
17. Durie FH, Campbell AM, Lee WR, Damato BE. Analysis of lymphocytic infiltration in uveal melanoma. Invest Ophthalmol Vis Sci 1990; 31:2106-2110
18. Duke JR, Dunn SN. Primary tumors of the iris. Arch Ophthalmol 1958; 59:204-214
19. Fine SL. How should we manage a patient with uveal melanoma (editorial). Arch Ophthalmol 1985; 103:910-911
20. Folberg R, Augsburger JJ, Gamel JW, Shields JA, Lang WR. Fine-needle aspirates of uveal melanomas and prognosis. Am J Ophthalmol 1985; 100:654-657
21. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993; 100:1389-1398
22. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 1992; 33:1919-1922
23. McGalliard JN, Johnston PB. A study of iris melanoma in Northern Ireland. Br J Ophthalmol 1989; 73:591-595
24. Geisse LJ, Robertson DM. Iris Melanomas. Am J Ophthalmol 1985; 99:638-648
25. Grossniklaus HE. Fine needle aspiration biopsy of the iris. Arch Ophthalmol 1992; 110:969-976
26. Grossniklaus HE, Brown RH, Stulting RD, Blasberg RD. Iris melanoma seeding through a trabeculectomy site. Arch Ophthalmol 1990; 108:1287-1290
27. Harbour JW, Augsburger JJ, Eagle RC. Initial management and follow up of melanocytic iris tumors. Ophthalmology 1995; 102:1987-1993
28. Heath P. Tumors of the iris: classification and follow-up. Trans Am Ophthalmol Soc 1964; 62:52-85
29. Henke V, Naumann GOH. Biozytologie diffuser maligner Melanome der vorderen Uvea. Klin Monatsbl Augenheilkd 1988; 192:289-295
30. Holland G. Zur Klinik und Pathologie der Pigmenttumoren der Iris. Klin Monatsbl Augenheilkd 1967; 150:359-370
31. Jakobiec FA, Silbert G. Are most iris "melanomas" really nevi? Arch Ophthalmol 1981; 99:2117-2132
32. Jacobiec AJ, Moormann LT, Jones IS. Benign epithelioid cell nevi of the iris. Arch Ophthalmol 1979; 97:917-921
33. Jensen OA. Malignant melanomas of the uvea in Denmark, 1943-1952 A clinical, histopathological and prognostic study. Acta Ophthalmol (Suppl) 1963; 75:141-189
34. Jensen OA. Malignant melanomas of the human uvea, 25 year follow up of cases in Denmark, 1943-1952. Acta Ophthalmol 1982; 60:161-182
35. Jonas JB. Biomorphometrie des Nervus Opticus. Universität Erlangen - Nürnberg, Habil.- Sehr. 1988
36. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-481
37. Katz NR, Finger PT, McCormick SA, Telloc C, Ritch R, Sirotra M, Kranz O. Ultrasound biomicroscopy in the management of malignant melanoma of the iris. Arch Ophthalmol 1995; 113 (11):1462-1463
38. Kersten RC, Tse DT, Anderson R. Iris melanoma, naevus or malignancy? Surv Ophthalmol 1985; 29 (6):423-433
39. Kersten RC, Tse DT, Anderson RL. Diffuse malignant melanoma of iris with metastases. Surv Ophthalmol 1991; 35(5):403
40. McLean IW, Forster WD, Zimmerman LE. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977; 95:48-58
41. McLean IW, Forster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983; 96:502-509
42. McLean IW, Forster WD, Zimmerman LE, Martin DG. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci 1980; 19:760-770
43. McLean IW, Zimmerman LE, Evans RM. Reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol 1978; 86:557-564
44. Mantel N, Haenszel W. Statistical aspects of the analysis of data for retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748
45. Margo CE, Groden LR. Iris melanoma with extensive corneal invasion and meatastases. Am J Ophthalmol 1987; 105:543-544
46. Memmen JE, McLean IW. The long-term outcome of patients undergoing iridocyclectomy. Ophthalmology 1990;97:429-432
47. Mooy CM, De Jong PTVM, Van der Kwast TH, Mulder PGH, Jager MJ, Ruiter DJ. Ki-67 immunostaining in uveal melanoma: The effect of pre-enucleation radiotherapy. Ophthalmology 1990; 97:1275-1280
48. Naumann GOH, Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroida and ciliary body. Arch Ophthalmol 1966; 76:784-796
49. Naumann GOH. Uvea. In: Naumann und Koautoren. Pathologie des Auges. In: Doer W, Seifert G, Uehlinger E (Hrsg) Spezielle pathologische Anatomie, Berlin, Springer 1980; 12:427-500
50. Pavlin CJ, McWhae JA, McGowan HD, Foster FS. Ultrasound biomicroscopy of anterior segment tumors. Ophthalmology 1992; 99:1220-1228
51. Raivio I. Uveal melanoma in Finnland: an epidemiological, clinical, histological and prognostic study. Acta Ophthalmol 1977:Suppl 133
52. Rones B, Zimmerman LE. the prognosis of primary tumors of the iris treated by iridectomy. Arch Ophthalmol 1958; 60:193-205
53. Rummelt V. Zur prognostischen Bedeutung der tumoreigenen Gefäßarchitektur in melanozytären Tumoren des Ziliarkörpers und der Aderhaut: Eine histopathologische Studie über 510 Tumoren und erste klinische Erfahrungen. Universität Erlangen - Nürnberg, Habil.- Schr. 1996
54. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J. Relation between the microcirculation architecture and the agressive behavior of ciliary body melanomas. Ophthalmology 1995; 102:844-851
55. Rummelt V, Naumann GOH. Uvea. In: Naumann GOH und Koautoren: Pathologie des Auges In: Doerr W, Seifert G, Uehlinger E (Hrsg) Berlin, Springer,1997; Band 12/I+II, S. 693-843
56. Sanborn GE, Ngyuen P, Gamel JW, Niederkorn JY. Reduction of enucleation-induced metastasis in intraocular melanoma by periorbital irradiation. Arch Ophthalmol 1987; 105:1260-1264
57. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101:1984-1989
58. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97:769-777
59. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977; 95:63-69
60. Shields JA, Shields CL. Hepatic metastases of diffuse iris melanoma 17 years after enucleation. Am J Ophthalmol 1988; 106:749-750
61. Shields CL, Shields JA, Shields MB, Augsburger JJ. Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology 1987; 94:839-846
62. Shields CL, Shields JA, Milite J, DePotter P, Sabbagh R, Menduke H. Uveal melanoma in teenagers and children. Report of 40 cases. Ophthalmology 1991; 98:1662-1666
63. Shields JA, Augsburger JJ, Bernadino VJR., Eller AW. Melanocytoma of the ciliary body and iris. Am J Ophthalmol 1980; 89:632-635
64. Sunba MSN, Rahi AHS, Path MRC, Morgan G, Path FRC. Tumors of the anterior uvea. Arch Ophthalmol 1980; 98:82-85
65. Zimmerman LE, McLean IW. Metastatic disease from untreated uveal melanomas. Am J Ophthalmol 1979; 88:524-534
66. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979; 87:741-760
67. Zimmerman LE, McLean IW, Forster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br J Ophthalmol 1978; 62:420-425